PMID- 24074324 OWN - NLM STAT- MEDLINE DCOM- 20140509 LR - 20190318 IS - 1557-900X (Electronic) IS - 0892-7790 (Linking) VI - 28 IP - 2 DP - 2014 Feb TI - Adverse events resulting from lasers used in urology. PG - 256-60 LID - 10.1089/end.2013.0451 [doi] AB - OBJECTIVE: To collate world reports of adverse events (AEs) resulting from lasers used in urology. METHODS: The Manufacturer and User Facility Device Experience (MAUDE) database of the United States Food and Drug Administration (FDA) was searched using the term "Laser for gastro-urology use." In addition, the Rockwell Laser Industries (RLI) Laser Accident Database was searched for the following types of lasers: neodymium-doped yttrium aluminum garnet (Nd:YAG), holmium:yttrium aluminum garnet (Ho:YAG), potassium titanyl phosphate (KTP), diode and thulium:YAG (Tm:YAG). RESULTS: Both databases were last accessed on October 1, 2012. Overall, there were 433 AEs; 166 in MAUDE database (1992-2012) and 267 in RLI database (1964-2005). Most of the AEs (198/433 or 46%) resulted from generator failure or fiber tip breaking. Whereas there were 20 (4.6%) AEs harming medical operators, there were 159 (37%) AEs harming nonmedical operators using Nd:YAG, KTP, and diode lasers. Eye injuries ranging from mild corneal abrasions to total vision loss were reported in 164 AEs with the use of Nd:YAG, KTP, and diode lasers. Overall, there were 36 (8.3%) AEs resulting in patient harm, including 7 (1.6%) mortalities, 3 deaths from ureteral perforation using the Ho:YAG laser, and 4 deaths from air emboli using the Nd:YAG laser. Other reported patient injuries included bladder perforation resulting in urinary diversion in a patient, in addition to minor skin burns, internal burns, and bleeding in others. There were no AEs reported with the use of Tm:YAG laser. CONCLUSIONS: Most of the AEs reported relate to equipment failure. There were no eye injuries reported with the use of Ho:YAG lasers. Caution must be exercised when using lasers in urology, including wearing appropriate eye protection when using Nd:YAG, KTP, and diode lasers. FAU - Althunayan, Abdulaziz M AU - Althunayan AM AD - Division of Urology, Department of Surgery, McGill University Health Center, McGill University, Montreal, Quebec, Canada. FAU - Elkoushy, Mohamed A AU - Elkoushy MA AD - Division of Urology, Department of Surgery, McGill University Health Center, McGill University, Montreal, Quebec, Canada; Department of Urology, Suez Canal University, Ismailia, Egypt FAU - Elhilali, Mostafa M AU - Elhilali MM FAU - Andonian, Sero AU - Andonian S LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20131119 PL - United States TA - J Endourol JT - Journal of endourology JID - 8807503 RN - 0 (yttrium-aluminum-garnet) RN - 58784XQC3Y (Yttrium) RN - CPD4NFA903 (Aluminum) SB - IM CIN - J Urol. 2015 Jan;193(1):170. PMID: 25523666 MH - Aluminum/*adverse effects MH - Eye Protective Devices MH - Humans MH - Laser Therapy/*adverse effects/instrumentation MH - Lasers, Semiconductor/*adverse effects MH - Lasers, Solid-State/*adverse effects MH - Postoperative Complications/*etiology MH - Treatment Outcome MH - Urologic Diseases/*complications/surgery MH - Yttrium/*adverse effects EDAT- 2013/10/01 06:00 MHDA- 2014/05/10 06:00 CRDT- 2013/10/01 06:00 PHST- 2013/10/01 06:00 [entrez] PHST- 2013/10/01 06:00 [pubmed] PHST- 2014/05/10 06:00 [medline] AID - 10.1089/end.2013.0451 [doi] PST - ppublish SO - J Endourol. 2014 Feb;28(2):256-60. doi: 10.1089/end.2013.0451. Epub 2013 Nov 19.